Publications by authors named "Francesca Fabbri"

Claim this Profile
T
The EXcellenT Trial: Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment.
Chiara Bennati, Roberto Ferrara, Sabina Sangaletti, Stefano Tamberi, Andrea Spadoni, Francesca Fabbri, Elisabetta Fabbri

Clin Lung Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in Systemic Therapies for Advanced Malignant Mesothelioma.
Chiara Deiana, Francesca Fabbri, Simona Tavolari, Andrea Palloni, Giovanni Brandi

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use of Antigenic SARS-CoV-2 Point-of-Care Test: The Italian Pediatric Real-Life Experience.
Federica Ferrari, Fortunata Civitelli, Francesca Ardenti Morini, Federico Angelo Carmelo Buonaiuto, Gianluca Frega, Francesca Fabbri

Clin Pediatr (Phila)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab.
Filippo G Dall'Olio, Diletta Calabrò, Nicole Conci, Giulia Argalia, Paola Valeria Marchese, Francesca Fabbri

Eur J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single- and multi-site pacing strategies for optimal cardiac resynchronization therapy: impact on device longevity and therapy cost.
Antonio D'Onofrio, Matteo Bertini, Tommaso Infusino, Girolamo D'Arienzo, Laura Cipolletta, Francesca Fabbri

J Interv Card Electrophysiol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Many Cancer Clinical Trials Can a Clinical Research Coordinator Manage? The Clinical Research Coordinator Workload Assessment Tool.
Francesca Fabbri, Giorgia Gentili, Patrizia Serra, Bernadette Vertogen, Daniele Andreis, Greta Fabbri

JCO Oncol Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of mutations in NSCLC: a new algorithm for patient selection and personalized treatment.
Fiamma Buttitta, Lara Felicioni, Alessia Di Lorito, Alessio Cortellini, Luciana Irtelli, Francesca Fabbri

Oncotarget· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
M Christina Cox, Sabrina Pelliccia, Luigi Marcheselli, Roberta Battistini, Annalisa Arcari, Francesca Fabbri

Invest New Drugs· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Maria Christina Cox, Gerardo Musuraca, Roberta Battistini, Ivana Casaroli, Valerio Zoli, Francesca Fabbri

Br J Haematol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.
Elisabetta Pietri, Daniele Andreis, Francesca Fabbri, Cecilia Menna, Alessio Schirone

Oncologist· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone.
Ugo De Giorgi, Paola Caroli, Salvatore L Burgio, Cecilia Menna, Vincenza Conteduca, Francesca Fabbri

Oncotarget· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone.
Salvatore Luca Burgio, Vincenza Conteduca, Cecilia Menna, Elisa Carretta, Lorena Rossi, Francesca Fabbri

Endocr Relat Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.
Laura Mercatali, Marianna Ricci, Emanuela Scarpi, Patrizia Serra, Francesca Fabbri

Int J Mol Sci· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: a pilot, randomized, intravascular ultrasound study.
Luciano Potena, Francesco Grigioni, Paolo Ortolani, Gaia Magnani, Francesca Fabbri

J Heart Lung Transplant· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics.
Francesco Grigioni, Andrea Barbieri, Antonio Russo, Letizia Reggianini, Silvia Bonatti, Francesca Fabbri

J Heart Lung Transplant· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation.
Francesco Grigioni, Antonio Russo, Luciano Potena, Alfonso Ielasi, Francesca Fabbri

J Heart Lung Transplant· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study.
Francesco Grigioni, Anna Chiara Musuraca, Eliana Tossani, Luciano Potena, Fabio Coccolo, Francesca Fabbri

Ital Heart J· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic aspects of 49,XXXXY syndrome.
Cinzia Galasso, Carla Arpino, Francesca Fabbri, Paolo Curatolo

J Child Neurol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis